课题基金 / 基金详情

Genome Editing Core

Genome Editing Core
基因组编辑核心
批准号:
10626064
负责人:
Peng Yi
金额:
$24.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-02-15 至 2027-03-31

项目摘要

项目成果

Peng Yi的其他基金

相似基金

相关文献

中文摘要
翻译
基因组编辑核心:摘要
英文摘要
GENOME EDITING CORE: Abstract Investigating mechanisms that underlie diabetes and its complications requires relevant experimental models. The Genome Editing Core (GEC) was established to assist investigators in generating cell and mouse models that can accelerate the development of new approaches to prevention, treatment, and ultimately a cure for diabetes. The GEC provides investigators the tools and expertise to leverage the latest CRISPR methodologies for the generation of both mouse and cellular models. The first component of this core, implemented approximately 5 years ago, is a mouse genome editing service. GEC staff assist investigators in the design and generation of custom mouse models with gene insertions, deletions and modifications of many kinds. The GEC is uniquely positioned to engineer the genome of the most relevant mouse models for diabetes, including the nonobese diabetic mouse model for type 1 diabetes and strains used in type 2 diabetes research (e.g. C57BL6 and C57BLKS). These models enable investigators to evaluate the consequences of genome edits at the systemic level in physiological conditions. The second component of this core enables powerful cell-based, genome-scale forward genetic screens through a CRISPR screening service and represents a major core evolution to meet the needs of the Joslin research base. GEC leadership brings outstanding expertise in this approach, and over the past year the core has acquired several genome-scale mouse and human CRISPR libraries and completed successful screens. In the present application, CRISPR screening services will be offered to perform genome-wide screens in the many various cell types to uncover mechanisms and identify novel targets in the pathogenesis of diabetes and its complications. In sum, the GEC provides a state-of-the art platform for DRC investigators to manipulate the genome of mouse and human cells at a small scale for specific hypothesis-driven projects and at a large scale for exploratory, hypothesis-generating research endeavors. The GEC further allows investigators to test genome edits in mouse models to explore gene function at the systemic level in physiological conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening
  • 批准号:
    10576864
  • 项目类别:
  • 资助金额:
    $42.25万
  • 财政年份:
    2018
  • 负责人:
    Peng Yi
  • 依托单位:
Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening
  • 批准号:
    10370397
  • 项目类别:
  • 资助金额:
    $42.25万
  • 财政年份:
    2018
  • 负责人:
    Peng Yi
  • 依托单位:
Genome Editing Core
  • 批准号:
    10407759
  • 项目类别:
  • 资助金额:
    $24.27万
  • 财政年份:
    1997
  • 负责人:
    Peng Yi
  • 依托单位:
海外基金